Company Legal Name
Latest Valuation
Founded Year
Headquarters
Persist AI operates an AI-powered laboratory that develops long-acting injectable drug formulations through advanced robotics and automation technologies. Founded in 2022 and headquartered in West Sacramento, the company addresses critical challenges in pharmaceutical development by accelerating the traditionally lengthy and costly process of creating sustained-release drug delivery systems. By combining artificial intelligence with automated laboratory processes, Persist AI enables pharmaceutical companies to rapidly prototype and optimize injectable formulations that can extend dosing intervals from daily to weekly or monthly administration. The company focuses on transforming drug delivery development through its integrated platform of machine learning algorithms and robotic experimentation capabilities.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
